StockWatch
·
SOMANY CERAMICS LTD. · QQ2 FY-2027 · THE CALL

Revenue soars but volume modest; margin recovery on track via product mix shift

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsSOMANYCERASOMANY CERAMICS LTD.11 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Met revenue guidance (+25.6% vs. +20%+ expected), margin guidance revised up (1-1.5%→2-2.5%), capex on track. Volume miss vs. prior double-digit aspiration (only 5.5%).

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong revenue growth (+25.6%) and margin recovery story (11.5-12% EBITDA guidance, GVT mix shift to 65-70%) are credible and supported by capex execution. However, Q2 volume of only 5.5% and industry export decline (-31%) mean near-term growth is price/mix-driven, not volume-driven. South plant upside is 12-18 months away. Hold pending Q3 volume acceleration.

₹860.6 Cr

Revenue · +25.6% YoY

₹41.6 Cr

Reported PAT · +237.6% YoY

Expanding

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Revenue growth 25%, volume 5.5%

MET

Delivered ₹860.6 Cr (+25.6% YoY), volume +5.5% confirms management claim; price/mix outpaced volume

EBITDA 11.7% due to better utilization and improved JVs

MET

Delivered OPM 11.3%, EBITDA claim 11.7% is plausible (EBITDA > OPM); JVs swung from ₹12 Cr loss to ₹3 Cr profit in Q2

GVT mix now 45%, targeting 65-70% via South plant

MET

45% current mix stated in call; South plant all-GVT expansion (16 million sq m) is credible mechanism. Not contradicted by Q2 numbers.

Gas prices ₹70/SCM, full pass-through achieved, 16-17% price increase April-now

MET

Q2 revenue +25.6% with only 5.5% volume = ~19% price/mix uplift; consistent with gas pass-through claim

Morbi exports down 31%, but Somany tiles +25%

MET

Industry export headwind -31.2%, Somany breakup tiles +25% (₹723 Cr), is internally consistent. Export decline is real headwind despite domestic strength.

Earnings quality

What changed since the last call

Deltas vs. the prior call

EBITDA margin guidance raised

Upgrade

Prior call: 1-1.5% FY27 margin improvement over FY26. This call: revised to 2-2.5% improvement, with FY27 target 11.5%-12%.

South capex structure refined

Neutral

Original: ₹275 Cr capex FY27-28, 65-70% equity-funded. Revised: ₹250 Cr South + ₹60 Cr Somany side + routine modernization, 50-50 debt-equity.

Volume growth reset lower

Downgrade

Q2 volume only 5.5% (vs. prior 'double-digit' aspiration). Management now guides 7-8% Q3, single-digit FY27. Export headwind (-31% industry) blamed.

JV profitability turned

Upgrade

Q2 prior year: ₹12 Cr loss. Q2 this year: ₹3 Cr profit. H1 swing from ₹23 Cr loss to ₹6 Cr profit. Positive inflection.

The Q&A

Analysts probed volume growth disappointment (5.5% in a +25% revenue quarter), Morbi crisis impact, gas pricing floor, and GVT ramp timeline. Management defended single-digit volume as expected, blamed export headwind & maintenance disruptions, addressed gas floor (tiles still cost-competitive), and confirmed South plant Sept 2027 production. No aggressive pushback; management held its guidance confidently.

The exchanges that mattered

Pricing sustainability & gas pass-through — Nilesh Sharma, Monomer Capital

Partial

Gas already down INR2-3 from peak April; further declines unlikely. Price increases are mix of gas + other costs. Full pass-through achieved. Gas currently ₹70/SCM, unlikely to spike further.

GVT mix & capex plans — Sagnik Sarkar, SKP Securities

Answered

GVT 45% now (up from 41%). Next 16M sq m all GVT; will hit 65-70% in 2-3 years. GVT higher margin but not a standalone lever; benefit is volume absorption + mix shift together.

Capacity utilization & gas pricing floor — Divaneet Savla, Savia Family Office

Answered

100% capacity utilization. Even if tiles prices rise 50% from current, still viable vs. alternatives. Gas supply not constrained. No viability threshold identified.

Volume growth trajectory & segment mix — Sneha, Nuvama

Answered

5.5% Q2 due to maintenance disruptions (20 days July, 15 days Aug). Expect 7-8% Q3. No double-digit guidance. Sanitaryware +20%, building solutions +28% (both high-margin, expanding capacity Sep 2027).

Medium to long-term margin trajectory — Shruti Mulchandani, Ikigai Asset Management

Partial

FY27 guidance 11.5-12% EBITDA. FY28-29 room for improvement. JVs will contribute positively (no margin drag next year). GVT capex accretive. 3-year view: upwards trajectory but not specifying number.

Bathware margins & pricing power — Karan Bhatelia, Asian Markets Securities

Answered

Bathware margins high & stable (couple bits above tiles). Q1 was drag (brass prices shot up); Q2 better. Project 4% hike is volume-based, realized 1.5% via pass-on + pricing. Mix shift to projects (+4%) and adhesive (+40-50% growth) adds 2% EBITDA margin spread over time.

Capacity post-South plant expansion — Bharat Kudikyala, Choice Institutional Equities

Answered

FY27 sales target 79-80M sq m. FY28 (mid-year South online) adds 10-11M sq m. Total capacity ~90M sq m by end FY28.

Guidance

Forward guidance and management's confidence

FY27 'high single digits' growth (post-H1 completion)

Medium

H1 growth 25.6% YoY, but export headwind & volume moderation (5.5% Q2) suggest FY27 tapers. Mid-teens growth estimate, not 25%+ sustained.

Sales target FY27: 79-80M sq m; FY28 (with South): 10-11M sq m addition

High

Specific, operational target. South plant capex on track, Sept 2027 firing (production). Credible.

FY27 EBITDA margins 11.5%-12% (raised from prior 1-1.5% improvement guidance)

High

Q2 achieved 11.7%; trajectory to 12% by year-end is incremental but credible via mix (GVT +4%, JV profit recovery).

FY28-29 margins upwards of 11.5%-12%, with room for improvement

Medium

South plant adds all-GVT capacity; margin accretive. But specific 13%+ target not given; deferred as multi-year story.

Sanitaryware & building solutions expand 20-28%; push 22-25% of total revenue in 2-3 years (from 16-17% now)

Medium

Growth rates proven in Q2, but high-margin products are low-absolute-volume currently. Margin contribution is real but gradual.

South capex ₹250 Cr (50-50 debt-equity); Somany side ₹60 Cr capex + routine modernization (Sudha ₹15 Cr, Vintage ₹8 Cr)

High

Detailed, on-track. Sept 2027 production deadline for South plant. Revised from original ₹275 Cr guidance but still in neighborhood.

Routine capex ₹70-80 Cr/year (Somany standalone) for debottlenecking & modernization

High

Annually funded from internal accruals per management statement.

Risks the call surfaced

Ranked by how much they should concern a holder

Geopolitical export headwind

Medium

Morbi (export hub) 35-45% shut due to Ukraine war impact on freight & land prices. Industry exports down 31.2%. Recovery timeline uncertain, dependent on geopolitical thaw.

Volume growth deceleration

Medium

Q2 volume only 5.5% despite 25.6% revenue growth. Price/mix (+19%) outpaced volume growth. Management resets guidance to 7-8% Q3, single-digit FY27. Risk: volume may remain pressured if demand weakens post-Diwali.

Gas price volatility

Low

Gas currently ₹70/SCM (up from ₹45 in FY26). Full pass-through achieved in Q2 (+16-17% pricing), but future spikes could hit margins if pricing power caps. War escalation risk remains.

South plant capex execution

Medium

₹250 Cr South capex for 16M sq m GVT expansion, targeted Sept 2027 production. Delay would push capacity ramp & GVT mix upside to FY29, delaying margin expansion & volume scale.

JV profitability sustainability

Low

Q2 prior: ₹12 Cr loss. Q2 current: ₹3 Cr profit. This swing inflates PAT growth (+237.6% YoY). Risk: if JV margins revert to loss, PAT would be heavily impacted. Exposure: ~₹3-6 Cr H1 swing is ~7-15% of Somany consolidated profit.

Management

Score 8/10. Clear & transparent on headwinds (Morbi export crisis, gas volatility, volume moderation). Detailed on capex plans (₹250 Cr South, Sept 2027 firing). Addresses analyst probes directly (capacity, pricing, GVT mix). No evasion detected. Acknowledges constraints (war, freight rates, volume cap at 5.5% this quarter) candidly. Revenue guidance met (+25.6% YoY vs. +20%+ expected). Margin guidance revised up (1-1.5% → 2-2.5%), now tracking 11.5-12% EBITDA for FY27. Capex on track (South plant Sept 2027 deadline credible). Volume guidance reset lower (double-digit aspiration → 5.5% Q2, 7-8% Q3) but execution honest.

What to watch next
  • 1 · Q3 FY27 (Dec 2026)

    Volume acceleration to 7-8%; export recovery post-Diwali/geopolitical relief

  • 2 · Sept 2027 (FY28)

    South plant ramp (16M sq m GVT capacity), GVT mix jump 45%→50%+

  • 3 · FY28-29

    GVT mix 65-70% achieved; margin target 12%+ via mix + capacity absorption

Hold pending Q3 volume acceleration.

Informational and educational content only. Not investment advice.